Public research body · Science policy · Washington, DC - Cambridge · Est. 2022
ARPA-H (Advanced Research Projects Agency for Health) is a U.S. federal biomedical R&D funding agency within the Department of Health and Human Services (HHS), associated with NIH but structured as an independent entity whose Director reports directly to the HHS Secretary. ARPA-H’s mission is to accelerate better health outcomes by funding and operating high-risk, high-reward biomedical and health research programs that are not readily accomplished through traditional research pathways or commercial activity.
Instead of simply issuing grants for discrete projects, ARPA-H builds multi-year programs—driven by term-limited Program Managers—that define measurable technical milestones, competitively select performer teams, and actively manage execution toward translation-ready outcomes. Strategically, ARPA-H emphasizes (1) platform- and systems-level approaches (e.g., new AI-enabled or standardized research ecosystems), (2) patient- and care-delivery-relevant engineering challenges (e.g., scalable clinical AI and next-generation diagnostics/monitoring), and (3) reproducibility and evaluation rigor through program design and external evaluation partners. In the current program portfolio, ARPA-H’s recent launches and award selections concentrate on accelerating “gold-standard” biomedical evidence generation (IGoR), deploying clinically authorized agentic AI for cardiovascular care (ADVOCATE), enabling distributed/on-demand genetic medicine manufacturing (GIVE), and building AI-ready data resources for rare disease diagnosis (RAPID), among other initiatives.
No curated programs yet. Check the careers page ↗.
<span>COSMOS</span> <span><span>kim.locraft@ar…</span></span> <time datetime="2026-09-16T11:50:36+00:00" title="Wednesday, September 16, 2026">September 16, 2026</time> <div class="field field--name-field-image field--type-entity-reference field--label-above"> <div class="field__
ASCENT-IBO<span>ASCENT-IBO</span> <span><span>jonathan.croni…</span></span> <time datetime="2026-08-03T16:12:34+00:00" title="Monday, August 3, 2026">August 3, 2026</time> <div class="field field--name-field-image field--type-entity-reference field--label-above"> <div class="field__label">
TIGAR Exploratory Topic<span>TIGAR Exploratory Topic </span> <span><span>kim.locraft@ar…</span></span> <time datetime="2026-04-17T18:54:33+00:00" title="Friday, April 17, 2026">April 17, 2026</time> <div class="field field--name-field-image field--type-entity-reference field--label-above"> <div class="
BRAINS Exploratory Topic<span>BRAINS Exploratory Topic</span> <span><span>kim.locraft@ar…</span></span> <time datetime="2026-04-17T16:39:02+00:00" title="Friday, April 17, 2026">April 17, 2026</time> <div class="field field--name-field-image field--type-entity-reference field--label-above"> <div class="
EVIDENT<span>EVIDENT</span> <span><span>andrea.stathop…</span></span> <time datetime="2025-11-25T18:03:17+00:00" title="Tuesday, November 25, 2025">November 25, 2025</time> <div class="field field--name-field-image field--type-entity-reference field--label-above"> <div class="field__lab
AI Cyber Challenge (AIxCC)<span>AI Cyber Challenge (AIxCC)</span> <span><span>jonathan.croni…</span></span> <time datetime="2025-01-17T15:05:42+00:00" title="Friday, January 17, 2025">January 17, 2025</time> <div class="field field--name-field-image field--type-entity-reference field--label-above"> <div c
Sprint for Women’s Health<span>Sprint for Women’s Health</span> <span><span>jonathan.croni…</span></span> <time datetime="2025-01-17T15:03:34+00:00" title="Friday, January 17, 2025">January 17, 2025</time> <div class="field field--name-field-image field--type-entity-reference field--label-above"> <div cl
Clear Brain Toxins in Women with Focused Ultrasound<span>Clear Brain Toxins in Women with Focused Ultrasound</span> <span><span>andrea.stathop…</span></span> <time datetime="2024-11-05T13:58:09+00:00" title="Tuesday, November 5, 2024">November 5, 2024</time> <div class="field field--name-body field--type-text-with-summary field--
Revolutionary Breakthroughs<span>Revolutionary Breakthroughs</span> <span><span>jonathan.croni…</span></span> <time datetime="2024-10-21T17:59:57+00:00" title="Monday, October 21, 2024">October 21, 2024</time> <div class="field field--name-field-front-content field--type-text-long field--label-above"> <div
Measurements of Chronic Pain<span>Measurements of Chronic Pain</span> <span><span>jonathan.croni…</span></span> <time datetime="2024-10-21T17:58:50+00:00" title="Monday, October 21, 2024">October 21, 2024</time> <div class="field field--name-field-front-content field--type-text-long field--label-above"> <di
ARPA-H launched the Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA) program to integrate biological, clinical, behavioral, and real-world data with computational tools to enable earlier and more accurate autism diagnosis and more precise care across the lifespan.
ARPA-H launches the world’s first bid to build FDA-authorized clinical AI for cardiovascular careARPA-H announced teams receiving contract awards under its ADVOCATE program to build an FDA-authorized, reliable clinical agentic AI system intended to serve as a 24/7 digital member of the cardiovascular care team; the announcement includes performer teams and program commitment for the first year and overall program cost.
ARPA-H selects teams to make made-to-order genetic medicine manufacturing possibleARPA-H selected performer teams under GIVE (Genetic Medicines and Individualized Manufacturing for Everyone) for distributed, automated RNA-based genetic medicine manufacturing and integrated quality control, with a stated program commitment up to $125 million.
ARPA-H announces awards to advance AI for rare disease diagnosis and treatmentARPA-H announced contract awards through RAPID (Rare Disease AI/ML for Precision Integrated Diagnostics) to build AI technologies and an AI-ready data resource intended to shorten diagnosis time and accelerate therapeutic development; the announcement states an investment up to $98.5 million over 4.5 years and names multiple performer-led teams plus data and in-kind support partners.
ARPA-H announced contract award teams under AIR (Autonomous Interventions and Robotics) to develop autonomous robotic systems and microbots intended to expand nationwide access to curative stroke care; the announcement names TA1 and TA2 performer teams and states a program commitment up to $175.3 million over 5 years.